These observations led us to analyse further the prevalence and kinetics of anti-NPM antibodies, their relationships with aCL antibodies in WB mouse and human SLE sera and the mechanisms that might account for the association between these two antibody populations. This evidence concerns the gene NPM1 and systemic lupus erythematosus.